NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q4 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $419,150 | -46.4% | 21,808 | -29.1% | 0.00% | 0.0% |
| Q2 2023 | $781,487 | -71.0% | 30,743 | -58.8% | 0.00% | -75.0% |
| Q1 2023 | $2,697,730 | -32.4% | 74,626 | -26.0% | 0.00% | -33.3% |
| Q4 2022 | $3,992,828 | -99.8% | 100,829 | +117.6% | 0.01% | +100.0% |
| Q2 2022 | $2,031,214,000 | -25.7% | 46,343 | +22.6% | 0.00% | -25.0% |
| Q1 2022 | $2,734,870,000 | +344.0% | 37,811 | +397.6% | 0.00% | +300.0% |
| Q4 2021 | $615,970,000 | -24.6% | 7,598 | +8.3% | 0.00% | 0.0% |
| Q3 2021 | $816,638,000 | -16.6% | 7,017 | +18.8% | 0.00% | 0.0% |
| Q2 2021 | $979,653,000 | +27.2% | 5,909 | +7.1% | 0.00% | 0.0% |
| Q1 2021 | $769,900,000 | -30.0% | 5,519 | -13.1% | 0.00% | -50.0% |
| Q4 2020 | $1,099,704,000 | -1.0% | 6,353 | -20.3% | 0.00% | 0.0% |
| Q3 2020 | $1,110,500,000 | +341.4% | 7,972 | +278.5% | 0.00% | – |
| Q2 2020 | $251,604,000 | -74.7% | 2,106 | -78.8% | 0.00% | -100.0% |
| Q1 2020 | $994,101,000 | -64.7% | 9,943 | -58.6% | 0.00% | -60.0% |
| Q4 2019 | $2,820,137,000 | +514.5% | 23,993 | +349.5% | 0.01% | +400.0% |
| Q3 2019 | $458,908,000 | +74.8% | 5,338 | +31.8% | 0.00% | 0.0% |
| Q2 2019 | $262,562,000 | -37.3% | 4,050 | -39.5% | 0.00% | 0.0% |
| Q1 2019 | $418,629,000 | +1509.1% | 6,697 | +901.0% | 0.00% | – |
| Q4 2018 | $26,017,000 | -72.4% | 669 | -59.5% | 0.00% | – |
| Q3 2018 | $94,221,000 | -25.7% | 1,653 | +4.0% | 0.00% | – |
| Q2 2018 | $126,882,000 | -75.4% | 1,589 | -73.3% | 0.00% | -100.0% |
| Q1 2018 | $516,120,000 | +30.7% | 5,955 | +4.1% | 0.00% | 0.0% |
| Q4 2017 | $394,978,000 | +34.8% | 5,721 | +77.5% | 0.00% | 0.0% |
| Q3 2017 | $292,997,000 | +13.2% | 3,224 | -7.3% | 0.00% | 0.0% |
| Q2 2017 | $258,868,000 | +442.8% | 3,478 | +583.3% | 0.00% | – |
| Q1 2017 | $47,693,000 | -62.9% | 509 | -71.2% | 0.00% | -100.0% |
| Q4 2016 | $128,463,000 | -37.8% | 1,768 | -10.6% | 0.00% | 0.0% |
| Q3 2016 | $206,379,000 | +198.3% | 1,977 | +110.8% | 0.00% | – |
| Q2 2016 | $69,187,000 | -68.6% | 938 | -71.3% | 0.00% | -100.0% |
| Q4 2015 | $220,488,000 | +40.2% | 3,266 | -3.7% | 0.00% | – |
| Q3 2015 | $157,308,000 | +131.9% | 3,391 | +168.7% | 0.00% | – |
| Q2 2015 | $67,833,000 | +665.0% | 1,262 | +582.2% | 0.00% | – |
| Q1 2015 | $8,867,000 | – | 185 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |